Jessie K. Kennedy

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area

W Keitel, Gail E. Potter, David Diemert et al. · Vaccine · 2019 · 65 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

Sean C. Murphy, Gregory A. Deye, B. Kim Lee Sim et al. · PLoS Pathogens · 2021 · 59 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial

Titus Divala, Randy G. Mungwira, Patricia Mawindo et al. · The Lancet Infectious Diseases · 2018 · 53 citations · Full text

Medicine, Maternal Health, Obstetrics +14

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

Brittany L Ober Shepherd, Paul T. Scott, Jack N Hutter et al. · The Lancet Microbe · 2024 · 53 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutics +16

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study

Guohua An, Daryl J. Murry, Kiran Gajurel et al. · Antimicrobial Agents and Chemotherapy · 2019 · 43 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15